Knoll, R. L., Brauny, M. M., Robert, E., Cloos, L., Waser, L., Hilbert, K., Ulmer, N., Hillen, B., Birkner, T., Bartolomaeus, T. U. P., Nitsche, O., Jarquín-Díaz, V. H., Lynch, S., Gehring, S., Maier, L., Poplawska, K., Forslund-Startceva, S. K. (2025). CFTR modulator therapy drives microbiome restructuring through improved host physiology in cystic fibrosis: the IMMProveCF phase IV trial. Nature Communications. https://doi.org/10.1038/s41467-025-64218-z